BPA order for radioactive diagnostic agent indicated for positron emission tomography (pet) of prostate specific membrane antigen (psma) positive lesions in men with prostate cancer.
Ended Awarded Last action
- Contract number
- 36C26123N0332
- Awardee
-
Progenics Pharmaceuticals Inc. UEI YLYKVRPCTCR3 Part of Lantheus Holdings, Inc.
- Awarding agency
-
Veterans Integrated Service Network 21
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $506,421
Award facts
- Contract value 100% obligated
- $506,420.80 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- Total Small Business
- Competition
- Full and Open Competition Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- North Billerica, Billerica, MA 01862, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$215,323 | |
| Original award | $721,744 |
About this award
Veterans Integrated Service Network 21 issued a BPA call to Progenics Pharmaceuticals Inc. for a radioactive diagnostic agent (PYLARIFY, piflufolastat F-18) indicated for positron emission tomography imaging of prostate-specific membrane antigen positive lesions in men with prostate cancer, with a ceiling value of $506,420.80, on February 1, 2023. The call is issued under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB). Performance occurs at North Billerica, Massachusetts. The call is firm fixed-price and designated as a total small business set-aside, with an ultimate completion date of September 30, 2023.
Quick answers
Who was awarded contract 36C26123N0332?
36C26123N0332 was awarded to Progenics Pharmaceuticals Inc. by Veterans Integrated Service Network 21 (Veterans Health Administration) on February 1, 2023.
How much is contract 36C26123N0332 worth?
The government has obligated $506,421 on 36C26123N0332.
Is contract 36C26123N0332 an order under another contract?
Yes. 36C26123N0332 is a BPA call under 36F79719D0170-36C26123A0014, a blanket purchase agreement, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C26123N0332 competed?
The extent of competition for 36C26123N0332 was full and open competition. It was set aside: Total Small Business.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award